Kumar, Sonal

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,277

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Harrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 497

Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: Clinical implications

Hajifathalian, K., Krisko, T., Mehta, A., Kumar, S., Schwartz, R., Fortune, B., Sharaiha, R. Z., Kaplan, A., Gonzalez, S., Skaf, D., et al. (2020) · Gastroenterology

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

Cited by 150

Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty

Hajifathalian, K., Mehta, A., Ang, B., Skaf, D., Shah, S. L., Saumoy, M., Dawod, Q., Dawod, E., Shukla, A., Aronne, L., et al. (2021) · Gastrointestinal Endoscopy

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 96

Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis.

Baig, M. U., Piazza, A., Lahooti, A., Johnson, K. E., Rangwani, S., Gouda, Z., Mahadev, S., Newberry, C., Hanscom, M., Sampath, K., et al. (2025) · Gastrointestinal Endoscopy

Diabetes Treatment and ManagementGastrointestinal Bleeding Diagnosis and Treatment

Cited by 54

Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: a systematic review and meta-analysis

Lange, M., Nadkarni, D., Martin, L., Newberry, C., Kumar, S., & Kushner, T. (2023) · Hepatology Communications

Dietary Effects on HealthLiver Disease Diagnosis and Treatment

Cited by 49

The feasibility, acceptability, and usability of telehealth visits

Sinha Gregory, N., Shukla, A. P., Noel, J. J., Alonso, L. C., Moxley, J., Crawford, A. J., Martin, P., Kumar, S., Leonard, J. P., & Czaja, S. J. (2023) · Frontiers in Medicine

Telemedicine and Telehealth ImplementationHealthcare Systems and Technology

Cited by 33

Mo1918: Gastrointestinal Symptoms from Semaglutide Are Common in Real-World Clinical Practice, Though Medication Discontinuation Rates Are Similar among Patients with or without Prior Digestive Complaints

Cornet, N., Rogers, L., Magahis, P. T., Sharaiha, R. Z., Yeung, M., Krisko, T., Buckholz, A., Kumar, S., & Newberry, C. (2023) · Gastroenterology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1